Diagnosis and management of malignant pleural effusions.
about
The Role of Interleukin-17 in Lung CancerThoracic complications and emergencies in oncologic patients.Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients.Does pleural fluid appearance really matter? The relationship between fluid appearance and cytology, cell counts, and chemical laboratory measurements in pleural effusions of patients with cancer.A fine decision tree consisted of CK5/6, IMP3 and TTF1 for cytological diagnosis among reactive mesothelial cells, metastatic adenocarcinoma of lung and non-lung origin in pleural effusionDiagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus.Minimally invasive surgical treatment of malignant pleural effusions.Diagnostic Utility of Pleural Fluid Cell Block versus Pleural Biopsy Collected by Flex-Rigid Pleuroscopy for Malignant Pleural Disease: A Single Center Retrospective Analysis.Calprotectin: a novel biomarker for the diagnosis of pleural effusion.The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusionMalignant pleural effusion in breast cancer 12 years after mastectomy that was successfully treated with endocrine therapy.A Novel Combination of Calprotectin and CXCL12 for Predicting Malignancy in Patients with Exudative Pleural Effusion.Evaluation of pleural effusion sCD26 and DPP-IV as diagnostic biomarkers in lung diseaseReactive oxygen species modulator 1 (Romo1) as a novel diagnostic marker for lung cancer-related malignant effusion.Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions.Tumor-induced CD8+ T-cell dysfunction in lung cancer patients.The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis.Malignant pleural effusions: appropriate treatment approaches.Switching off malignant pleural effusion formation-fantasy or future?Diagnostic value of medical thoracoscopy in malignant pleural effusion.Diagnostic Value of Neuron-Specific Enolase (NSE) and Cancer Antigen 15-3 (CA 15-3) in the Diagnosis of Pleural EffusionsVascular endothelial growth factor and protein level in pleural effusion for differentiating malignant from benign pleural effusion.High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients.Diagnostic value of interleukin 22 and carcinoembryonic antigen in tuberculous and malignant pleural effusions.Malignant pleural effusion: further translational research is crucial.Pleurodesis Using Mistletoe Extract Delivered via a Spray Catheter during Semirigid Pleuroscopy for Managing Symptomatic Malignant Pleural Effusion.Delayed breast cancer relapse with pleural metastasis and malignant pleural effusion after long periods of disease-free survival
P2860
Q28066949-EE652E18-7CFA-47EC-9F77-AD3AA3731F8FQ33554568-2D42AD6B-CEDF-4E58-9B53-D72D3FDA630CQ33698128-348085D6-21AB-4CF4-800E-4138CC2F5896Q34105039-66C9338C-BA7D-4C89-9D8C-B7A7F6738CEFQ34371378-1254724C-17A6-46F4-BA30-C2B3C300BEC6Q35080864-9DBD9723-89AF-4C2B-A990-1E32F85D06F4Q36014057-F3874F4B-D824-4B5F-9E8B-229FCC3A2F50Q36082600-0D64CF8F-C22A-4C9A-A6AF-23009D488197Q36202696-BD03892F-CA35-481A-BE5D-4449D15BF06FQ36419142-D3071B37-28A8-4487-BC88-0175EC79EB3DQ36907325-DC6DE22B-C525-44B2-A69C-CA96A38592EEQ36979544-AFA0A322-57F7-445E-935C-EF15E3AE0B27Q37328634-1AAD62A4-2F14-434B-8AB8-9AD44938541BQ37559570-34E00C4C-CDB8-415E-90BA-C7C4279365A7Q37619567-234371B2-9B68-4573-A80B-67B2691C18AFQ37652155-E5420C9B-4746-4FD8-A85B-CAC922AF6204Q38057233-832DA764-3E2D-4A8C-8D4D-0718B060873FQ38238738-38E649FA-7B3B-4B2F-BA45-082F38E44ADAQ38327770-4C69CCD3-2CB3-44FA-AED5-572629466E1DQ38543525-F932F735-F0BB-4281-A4E2-005AC3867643Q38640366-91136578-3716-471B-87A9-F5E44CAB4344Q41461500-E3735372-BB11-4470-B097-70EABE0269F0Q41619101-CC75EB46-4135-4D8C-934A-C789F2AC9592Q42316845-8BFED987-4593-4BED-A56C-E0474C5AEA78Q43078563-4BE2C9E5-6D35-42F2-8968-C4B1E1162769Q43195730-84F8CD22-9EEE-47E4-AF8C-776DCD0534CCQ47713873-F1E65E29-6388-4D2D-833A-7A2D4A252661Q58550113-2745AF6A-13E2-4A24-A8E4-2E60669F9C8E
P2860
Diagnosis and management of malignant pleural effusions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diagnosis and management of malignant pleural effusions.
@en
Diagnosis and management of malignant pleural effusions.
@nl
type
label
Diagnosis and management of malignant pleural effusions.
@en
Diagnosis and management of malignant pleural effusions.
@nl
prefLabel
Diagnosis and management of malignant pleural effusions.
@en
Diagnosis and management of malignant pleural effusions.
@nl
P2860
P1433
P1476
Diagnosis and management of malignant pleural effusions.
@en
P2093
John E Heffner
P2860
P356
10.1111/J.1440-1843.2007.01154.X
P577
2008-01-01T00:00:00Z